Today in @HealthAffairs, I join with coauthors, led by @JasonShafrin, in proposing that @CMSGov implement an approach to move drug price negotiations towards a paradigm based on treatment value.
https://t.co/dYlYLARgHF @TuftsCEVR@UW_Pharmacy @SchaefferCenter @ISPORorg